Boehringer Ingelheim Kg

Boehringer Ingelheim Gmbh

C. H. Boehringer Sohn

Ilse Streller

Kurt Schromm

Ernst-Otto Renth

Anton Mentrup

Armin Fugner

Wolfgang Hoefke

Herbert Merz

Dietrich Arndts

Werner Stransky

Wolfram Gaida

Enzio Mueller

Matthias Grauert

Franz J Kuhn

Gerd Schnorrenberg

Otto Roos

Walter Losel

Helmut Ensinger

Gunter Schingnitz

Adrian Carter

Ingrid Wiedemann

Alexander Walland

Novel benzomorphan derivatives of the formula ##STR1## wherein R.sup.1 -R.sup.8 are as defined herein. The benzomorphan derivatives are useful for treating cerebral ischaemia of various origins, epilepsy and neurodegenerative diseases.

Benzomorphan derivatives

Useful for treating neurodegenerative diseases

Amino acid derivatives of general formula ##STR1## (the definitions of the various symbols being explained in the specification) are suitable for treating high blood pressure and for cardioprotection. The new compounds are prepared and used in the usual way.

Amino acid derivatives and their pharmaceutical use

The invention relates to the use of 2-[N-(2,6-dichlorophenyl)-N-allylamino]-2-imidazoline as a cytoprotective agent.

Use of 2-(N-2,6-dichlorophenyl-N-allylamino)-2-imidazoline as

Compounds of the formula ##STR1## wherein Het is ##STR2## n is an integer from 1 to 4, inclusive, preferably 2 or 3, R.sub.1 is H or acyl,

Heterocyclic compounds

1-phenyl-2-(heterocyclyl-alkyl-amino)-ethanols

The invention relates to compounds of general formula I ##STR1## (wherein R.sub.1 and R.sub.2, which may be the same or different, each represents a hydrogen atom or a (C.sub.1 -C.sub.4) alkyl group;

3,1 Benzoxazin-2-ones and use thereof

Growing community of inventors

Stromberg, Germany

Ilse Streller